List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 46 studies with search of: Enfuvirtide OR Fuzeon[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance
Condition: HIV Infections
Interventions: Other: Interruption of enfuvirtide;   Other: enfuvirtide interrupton
2 Active, not recruiting Effect of an Enfuvirtide-Based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults
Condition: HIV Infections
Interventions: Drug: Emtricitabine;   Drug: Enfuvirtide;   Drug: Ritonavir;   Drug: Saquinavir;   Drug: Tenofovir disoproxil fumarate
3 Active, not recruiting Cohort Study for Patients Using Fuzeon (Enfuvirtide)
Conditions: HIV Infections;   Antiretroviral Treatment
Interventions: Drug: Fuzeon (Enfuvirtide);   Procedure: Laboratory diagnostic (CD4-cells);   Procedure: Laboratory diagnostics (HIV-1 viral load);   Drug: antiretroviral co-medication beside Fuzeon
4 Completed WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.
Condition: HIV Infections
Intervention: Drug: enfuvirtide [Fuzeon]
5 Active, not recruiting Intensification With Enfuvirtide in Naive HIV-Infected Patients (ANRS130)
Conditions: HIV Infections;   AIDS
Interventions: Drug: enfuvirtide;   Drug: emtricitabine/tenofovir disoproxil fumarate;   Drug: efavirenz or lopinavir/r
6 Terminated ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: Antiretroviral therapy
7 Active, not recruiting INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: Optimized background ARV therapy
8 Completed AMICI Study: A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients.
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: Optimized ARV background;   Drug: Integrase inhibitor
9 Completed Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Enfuvirtide T/20/Ro 29,9800, HIV-1 Infusion Inhibitor
10 Completed A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: Optimized Background ARVs
11 Completed BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: enfuvirtide [Fuzeon]
12 Completed BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: PI;   Drug: Background ARVs
13 Completed QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: ARV regimen
14 Completed A Study to Evaluate the Safety and Efficacy of Adding Fuzeon (Enfuvirtide) to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: HAART
15 Completed Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load
Condition: HIV Infections
Interventions: Drug: Enfuvirtide;   Drug: Raltegravir
16 Completed Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children
Condition: HIV Infections
Intervention: Drug: Enfuvirtide
17 Completed T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs
Condition: HIV Infections
Intervention: Drug: Enfuvirtide
18 Completed A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults
Condition: HIV Infections
Interventions: Drug: Enfuvirtide;   Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Efavirenz
19 Active, not recruiting Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects
Condition: HIV Infections
Intervention: Drug: Raltegravir
20 Completed Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)
Conditions: Leukoencephalopathy, Progressive Multifocal;   HIV Infections
Interventions: Drug: Enfuvirtide;   Drug: Tenofovir-Emtricitabine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services